Drug class
Cyclooxygenase 2 Inhibitors clinical trials
A class of medicines: the studies that test any of its 14 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the cyclooxygenase 2 inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
- Topical Celecoxib
- 1
- Nimesulide-Hyaluronic Acid Conjugate CA102N
- 1
- COX-2 Inhibitor ECP-1014
- 1
Studies by the year they started
656 studies that test it; most in 2003 (69); 3 more planned to start later
| Year | Studies |
|---|---|
| 1998 | 7 |
| 1999 | 4 |
| 2000 | 12 |
| 2001 | 22 |
| 2002 | 45 |
| 2003 | 69 |
| 2004 | 55 |
| 2005 | 25 |
| 2006 | 33 |
| 2007 | 18 |
| 2008 | 29 |
| 2009 | 25 |
| 2010 | 26 |
| 2011 | 27 |
| 2012 | 14 |
| 2013 | 18 |
| 2014 | 25 |
| 2015 | 19 |
| 2016 | 23 |
| 2017 | 17 |
| 2018 | 18 |
| 2019 | 26 |
| 2020 | 12 |
| 2021 | 19 |
| 2022 | 19 |
| 2023 | 14 |
| 2024 | 12 |
| 2025 | 14 |
| 2026 | 9 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 219 · Other 448
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (32) · Pfizer (30) · Boehringer Ingelheim (22) · National Cancer Institute (NCI) (18) · Organon and Co (15) · Novartis (13) · Heron Therapeutics (12) · M.D. Anderson Cancer Center (10)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 667
- Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric AdenotonsillectomyNot yet recruitingPhase 1/2NYU Langone HealthNCT07870447Written as Celecoxib
- Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic SurgeriesRecruitingPhase 4Northwell HealthNCT06379425Written as Celecoxib
- Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationRecruitingPhase 2Mayo ClinicNCT06997068Written as Celecoxib
- A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic CholangiocarcinomaNot yet recruitingPhase 1/2Shanghai 6th People's HospitalNCT07632235Written as Celecoxib + Pembrolizumab + Gemcitabine/Cisplatin
- Evaluation of the Safety and Efficacy of Parecoxib in Patients With Subarachnoid HemorrhageRecruitingPhase 2St. Anne's University Hospital Brno, Czech RepublicNCT06579274Written as Parecoxib
- Celecoxib for ENT Pain ManagementRecruitingPhase 2University of Wisconsin, MadisonNCT06505187Written as Celecoxib
- TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin TherapyNot yet recruitingPhase 2Myopharm LimitedNCT07139405Written as Celecoxib
- A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)RecruitingNot applicableMemorial Sloan Kettering Cancer CenterNCT05429970Written as Etodolac
- Pre-Emptive Parecoxib Sodium for Pain Control During CT-Guided Lung Nodule LocalizationRecruitingPhase 4Long JiangNCT07675473Written as PARECOXIB SODIUM
- Timed Aspirin Chronobiome StudyNot yet recruitingEarly Phase 1University of PennsylvaniaNCT03590821Written as Celecoxib 200mg capsule
- Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal CancerRecruitingPhase 2Sun Yat-sen UniversityNCT06903858Written as Toripalimab plus celecoxib
- SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID DysfunctionNot yet recruitingPhase 2Icahn School of Medicine at Mount SinaiNCT07597902Written as Celecoxib
- Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive CapsulitisRecruitingNot applicableKonya Beyhekim Training and Research HospitalNCT07493226Written as acetic acid derivatives
- Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee OsteoarthritisRecruitingPhase 4Northwestern UniversityNCT06245109Written as Celecoxib
- Stony Brook Medicine Anti-Inflammatory TrialNot yet recruitingPhase 4Stony Brook UniversityNCT06699966Written as Celecoxib
- Etoricoxib in Patients With Parkinsonian DiseaseRecruitingPhase 2Ihab Elsayed HassanNCT07370532Written as Etoricoxib
- Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal CancerRecruitingPhase 2Zhejiang UniversityNCT05731726Written as Celecoxib
- Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver CancerRecruitingPhase 2Emory UniversityNCT07174570Written as Celecoxib
- Meloxicam in Mohs Micrographic SurgeryRecruitingPhase 4University of OklahomaNCT07200544Written as Meloxicam 7.5 mg
- Celecoxib in Parkinson Disease as Adjuvant TherapyRecruitingPhase 1/2Tanta UniversityNCT07246278Written as Celecoxib 200mg
See all 667 studies that test one of the cyclooxygenase 2 inhibitors →
Codes
What other systems call Cyclooxygenase 2 Inhibitors · ClinicalTrials.gg INT008877
- MeSH (NLM) D052246Cyclooxygenase 2 InhibitorsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D052246 | Cyclooxygenase 2 Inhibitors | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.